These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 9131486)

  • 1. Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans.
    Wilkinson GR
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):475-90. PubMed ID: 9131486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects.
    Dresser GK; Schwarz UI; Wilkinson GR; Kim RB
    Clin Pharmacol Ther; 2003 Jan; 73(1):41-50. PubMed ID: 12545142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo drug interactions involving human CYP3A.
    Thummel KE; Wilkinson GR
    Annu Rev Pharmacol Toxicol; 1998; 38():389-430. PubMed ID: 9597161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of intestinal and hepatic cytochrome P4503A in murine Toxoplasma infection. Effects of N-acetylcysteine and N(G)-monomethyl-L-arginine on the hepatic suppression.
    Berg-Candolfi M; Candolfi E; Benet LZ
    Xenobiotica; 1996 Apr; 26(4):381-94. PubMed ID: 9173679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers.
    Raeissi SD; Hidalgo IJ; Segura-Aguilar J; Artursson P
    Pharm Res; 1999 May; 16(5):625-32. PubMed ID: 10350002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo.
    von Moltke LL; Greenblatt DJ; Duan SX; Harmatz JS; Wright CE; Shader RI
    J Clin Psychopharmacol; 1996 Apr; 16(2):104-12. PubMed ID: 8690825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of epinastine, a histamine H1 receptor antagonist, in human liver microsomes in comparison with that of terfenadine.
    Kishimoto W; Hiroi T; Sakai K; Funae Y; Igarashi T
    Res Commun Mol Pathol Pharmacol; 1997 Dec; 98(3):273-92. PubMed ID: 9485522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dirithromycin on human CYP3A in vitro and on pharmacokinetics and pharmacodynamics of terfenadine in vivo.
    Goldberg MJ; Ring B; DeSante K; Cerimele B; Hatcher B; Sides G; Wrighton S
    J Clin Pharmacol; 1996 Dec; 36(12):1154-60. PubMed ID: 9013373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of CYP3A activities in a subclone of Caco-2 cells (TC7) and human intestine.
    Raeissi SD; Guo Z; Dobson GL; Artursson P; Hidalgo IJ
    Pharm Res; 1997 Aug; 14(8):1019-25. PubMed ID: 9279883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2004 Sep; 76(3):250-69. PubMed ID: 15371986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic contribution to variable human CYP3A-mediated metabolism.
    Lamba JK; Lin YS; Schuetz EG; Thummel KE
    Adv Drug Deliv Rev; 2002 Nov; 54(10):1271-94. PubMed ID: 12406645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine.
    Lampen A; Zhang Y; Hackbarth I; Benet LZ; Sewing KF; Christians U
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1104-12. PubMed ID: 9618413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.
    Paine MF; Khalighi M; Fisher JM; Shen DD; Kunze KL; Marsh CL; Perkins JD; Thummel KE
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1552-62. PubMed ID: 9400033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat and human liver cytochrome P-450 isoform metabolism of ecteinascidin 743 does not predict gender-dependent toxicity in humans.
    Reid JM; Kuffel MJ; Ruben SL; Morales JJ; Rinehart KL; Squillace DP; Ames MM
    Clin Cancer Res; 2002 Sep; 8(9):2952-62. PubMed ID: 12231541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can oral midazolam predict oral cyclosporine disposition?
    Paine MF; Davis CL; Shen DD; Marsh CL; Raisys VA; Thummel KE
    Eur J Pharm Sci; 2000 Nov; 12(1):51-62. PubMed ID: 11121733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent intestinal and hepatic first-pass metabolism of midazolam, a cytochrome P450 3A substrate with differently modulated enzyme activity in rats.
    Higashikawa F; Murakami T; Kaneda T; Kato A; Takano M
    J Pharm Pharmacol; 1999 Jan; 51(1):67-72. PubMed ID: 10197420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.
    Lalovic B; Phillips B; Risler LL; Howald W; Shen DD
    Drug Metab Dispos; 2004 Apr; 32(4):447-54. PubMed ID: 15039299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the clinical development of cytochrome p450 3A substrates.
    Gibbs MA; Hosea NA
    Clin Pharmacokinet; 2003; 42(11):969-84. PubMed ID: 12908853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.